CompletedPhase 3

Budesonide for Maintenance Treatment of Collagenous Colitis

Germany75 participantsStarted 2004-07

Plain-language summary

The purpose of this study is to determine whether orale budesonide is effective in maintaining clinical remission in patients with collagenous colitis.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * collagenous colitis * diarrhea * written informed consent Exclusion Criteria: * infectious causes for diarrhea * other inflammatory bowel diseases * history of colonic surgery * celiac disease * malignancies * severe concomitant diseases * use of budesonide, steroids, mesalazine within the previous 2 weeks * known intolerance to budesonide * history of lack of response to budesonide * pregnancy,lactation * drug and/or alcohol abuse * lack of compliance

What they're measuring

Proportion of patients in clinical remission after 6 months

Trial details

NCT IDNCT00180076

SponsorTechnische Universität Dresden

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2007-03

View on ClinicalTrials.gov More Collagenous Colitis trials